France – Pharmaceutical products – Marché UNICANCER de la fourniture et de la livraison de médicaments 26-28 - Troisième vague
Opportunity Score
Confidence: 40%
Complexity: medium
2 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation
AI Analysis Summary
This notice, published by UNICANCER ACHATS (France), is an open EU tender for a framework agreement for the supply and delivery of various pharmaceutical products (oncology drugs) to UNICANCER member institutions. The tender includes 8 lots covering common administrative part, pemetrexed, trabectedine, eribulin, and enoxaparin. The procedure is a re-launch of lots that received no response. No estimated value, eligibility criteria, or award criteria are provided in the available data. Submission is electronic, in French, with a tight deadline of 15 days from publication. Procurement documents were not analyzed.
Strengths
Documents available
Open procedure
Medium complexity
Risks
Submission deadline in 2 days
Analysis may be incomplete
Only part of the procurement documentation was analyzed. Additional eligibility requirements, certificates, or submission documents may exist in the remaining tender documentation.
Key Requirements
- Electronic submission via Open portal
- Submission language: French.
- Tenders may be submitted for up to 8 lots (maximum awarded lots: 8).
Buyer
Name
UNICANCER ACHATS
Location
PARIS, FRA
Website
Buyer profile
Identifier
49118605200024
Lots (8)
Common administrative part for the framework agreement.
Supply of pemetrexed solution 1000mg/40ml.
Supply of pemetrexed solution 500mg/20ml.
Procurement Details
Publication
02 Jun 2026
Deadline
17 Jun 2026, 12:00
Procedure
open
Contract
supplies
Duration
24 MONTH
Language
FRA
Publication #
381847-2026
Classification
Performance: France
Documents (2)
Opportunity Score
Confidence: 40%
Complexity: medium
2 days
Deadline
supplies
Contract
Deep Portfolio Analysis
- Company fit score
- Missing certificates
- Eligibility blockers
- Bid / No-Bid recommendation